MedTrace Logo

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

NCT04054310 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2026-05-19

No results posted yet for this study

Summary

To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.

Conditions

  • NASH - Nonalcoholic Steatohepatitis

Interventions

DIAGNOSTIC_TEST

Liver Multi Scan

MRI to create cT1, T2\* and PDFF images of patients liver.

Sponsors & Collaborators

  • Perspectum

    lead INDUSTRY

Principal Investigators

  • Arun Sanyal, M.D. · VCU School of Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-05
Primary Completion
2026-06-01
Completion
2026-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04054310 on ClinicalTrials.gov